Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulmonary is a healthcare technology company focused on improving the diagnosis and management of respiratory diseases through artificial intelligence and digital health solutions. The company's primary platform, Pulmonary.ai, utilizes advanced algorithms to analyze respiratory data and provide clinicians with actionable insights for conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. By integrating with existing medical hardware and electronic health records, Pulmonary aims to streamline the diagnostic workflow and enhance patient outcomes in pulmonary medicine. Their services are designed to support both primary care physicians and specialists in identifying early-stage respiratory decline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulmonary.